Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-26

Clinical Trial Update: Inulin in Burn-induced Insulin Resistance [NA]

View source ↗

Summary

A University of Belgrade trial is evaluating inulin for burn-induced insulin resistance and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inulin (inulin)

Snippet

Sponsor: University of Belgrade | Conditions: Burn Injury, Insulin Resistance | NA | Status: NOT_YET_RECRUITING